Sandhya Upasani

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
302 Background: Our purpose was to assess the utilization of dose escalated radiotherapy (RT) in Stage III NSCLC patients in the United States from 2004-2013, a period when no Level 1 evidence on dose escalation was published. METHODS Data on all NSCLC patients treated with RT were extracted from the National Oncology Data Alliance (NODA), a pooled(More)
  • 1